Systematic Review on the Role of IL-6 and IL-1β in Cardiovascular Diseases
Cardiovascular diseases (CVDs) are a leading cause of global morbidity and mortality, significantly driven by chronic inflammation. Interleukin-6 (IL-6) and interleukin-1β (IL-1β) are critical inflammatory cytokines implicated in CVD progression. This systematic review evaluates the roles of IL-6 an...
Saved in:
| Published in | Journal of cardiovascular development and disease Vol. 11; no. 7; p. 206 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
MDPI AG
01.07.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Cardiovascular diseases (CVDs) are a leading cause of global morbidity and mortality, significantly driven by chronic inflammation. Interleukin-6 (IL-6) and interleukin-1β (IL-1β) are critical inflammatory cytokines implicated in CVD progression. This systematic review evaluates the roles of IL-6 and IL-1β in CVDs by synthesizing data from relevant studies to understand their impact on cardiovascular outcomes and identify potential therapeutic interventions. A comprehensive literature search was conducted using PubMed and Embase, covering studies from January 2014 to December 2024. Inclusion criteria encompassed studies investigating IL-6 and/or IL-1β in CVDs, including human and relevant animal models, and reporting clinical outcomes, molecular mechanisms, or therapeutic interventions. Data extraction and quality assessment were performed independently by two reviewers. Our review included 12 studies focusing on the roles of IL-6 and IL-1β in various CVDs. Elevated IL-6 levels were significantly associated with peripheral artery disease, myocardial infarction, and heart failure, while IL-1β levels were linked to worse outcomes in coronary artery disease and heart failure. Meta-analyses indicated a significant association between higher IL-6 and IL-1β levels and increased risk of adverse cardiovascular events. These findings suggest that targeting IL-6 and IL-1β could offer promising therapeutic strategies for reducing inflammation and improving cardiovascular outcomes. |
|---|---|
| AbstractList | Cardiovascular diseases (CVDs) are a leading cause of global morbidity and mortality, significantly driven by chronic inflammation. Interleukin-6 (IL-6) and interleukin-1β (IL-1β) are critical inflammatory cytokines implicated in CVD progression. This systematic review evaluates the roles of IL-6 and IL-1β in CVDs by synthesizing data from relevant studies to understand their impact on cardiovascular outcomes and identify potential therapeutic interventions. A comprehensive literature search was conducted using PubMed and Embase, covering studies from January 2014 to December 2024. Inclusion criteria encompassed studies investigating IL-6 and/or IL-1β in CVDs, including human and relevant animal models, and reporting clinical outcomes, molecular mechanisms, or therapeutic interventions. Data extraction and quality assessment were performed independently by two reviewers. Our review included 12 studies focusing on the roles of IL-6 and IL-1β in various CVDs. Elevated IL-6 levels were significantly associated with peripheral artery disease, myocardial infarction, and heart failure, while IL-1β levels were linked to worse outcomes in coronary artery disease and heart failure. Meta-analyses indicated a significant association between higher IL-6 and IL-1β levels and increased risk of adverse cardiovascular events. These findings suggest that targeting IL-6 and IL-1β could offer promising therapeutic strategies for reducing inflammation and improving cardiovascular outcomes. Cardiovascular diseases (CVDs) are a leading cause of global morbidity and mortality, significantly driven by chronic inflammation. Interleukin-6 (IL-6) and interleukin-1β (IL-1β) are critical inflammatory cytokines implicated in CVD progression. This systematic review evaluates the roles of IL-6 and IL-1β in CVDs by synthesizing data from relevant studies to understand their impact on cardiovascular outcomes and identify potential therapeutic interventions. A comprehensive literature search was conducted using PubMed and Embase, covering studies from January 2014 to December 2024. Inclusion criteria encompassed studies investigating IL-6 and/or IL-1β in CVDs, including human and relevant animal models, and reporting clinical outcomes, molecular mechanisms, or therapeutic interventions. Data extraction and quality assessment were performed independently by two reviewers. Our review included 12 studies focusing on the roles of IL-6 and IL-1β in various CVDs. Elevated IL-6 levels were significantly associated with peripheral artery disease, myocardial infarction, and heart failure, while IL-1β levels were linked to worse outcomes in coronary artery disease and heart failure. Meta-analyses indicated a significant association between higher IL-6 and IL-1β levels and increased risk of adverse cardiovascular events. These findings suggest that targeting IL-6 and IL-1β could offer promising therapeutic strategies for reducing inflammation and improving cardiovascular outcomes.Cardiovascular diseases (CVDs) are a leading cause of global morbidity and mortality, significantly driven by chronic inflammation. Interleukin-6 (IL-6) and interleukin-1β (IL-1β) are critical inflammatory cytokines implicated in CVD progression. This systematic review evaluates the roles of IL-6 and IL-1β in CVDs by synthesizing data from relevant studies to understand their impact on cardiovascular outcomes and identify potential therapeutic interventions. A comprehensive literature search was conducted using PubMed and Embase, covering studies from January 2014 to December 2024. Inclusion criteria encompassed studies investigating IL-6 and/or IL-1β in CVDs, including human and relevant animal models, and reporting clinical outcomes, molecular mechanisms, or therapeutic interventions. Data extraction and quality assessment were performed independently by two reviewers. Our review included 12 studies focusing on the roles of IL-6 and IL-1β in various CVDs. Elevated IL-6 levels were significantly associated with peripheral artery disease, myocardial infarction, and heart failure, while IL-1β levels were linked to worse outcomes in coronary artery disease and heart failure. Meta-analyses indicated a significant association between higher IL-6 and IL-1β levels and increased risk of adverse cardiovascular events. These findings suggest that targeting IL-6 and IL-1β could offer promising therapeutic strategies for reducing inflammation and improving cardiovascular outcomes. |
| Author | Sailybayeva, Aliya Bekbossynova, Makhabbat Katkenov, Nurlubek Kozhakhmetov, Samat Kushugulova, Almagul Mukhatayev, Zhussipbek |
| Author_xml | – sequence: 1 givenname: Nurlubek orcidid: 0000-0002-0747-7712 surname: Katkenov fullname: Katkenov, Nurlubek – sequence: 2 givenname: Zhussipbek surname: Mukhatayev fullname: Mukhatayev, Zhussipbek – sequence: 3 givenname: Samat orcidid: 0000-0001-9668-0327 surname: Kozhakhmetov fullname: Kozhakhmetov, Samat – sequence: 4 givenname: Aliya surname: Sailybayeva fullname: Sailybayeva, Aliya – sequence: 5 givenname: Makhabbat surname: Bekbossynova fullname: Bekbossynova, Makhabbat – sequence: 6 givenname: Almagul orcidid: 0000-0001-9479-0899 surname: Kushugulova fullname: Kushugulova, Almagul |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39057626$$D View this record in MEDLINE/PubMed |
| BookMark | eNptkU1P3DAQhi1ExfeNc2Wplx6a4o_ETo5oS2HFSkh8nK1ZZ0y9ysZgJyD-Fj-E34RhASHU08zYz7yamXebrPehR0L2OfstZcMOFrZtOWeaCabWyJaQrC5kKar1T_km2UtpwRjjuWJcbJDN3FppJdQWOb14SAMuYfCWnuOdx3saejr8Q3oeOqTB0emsUBT69iXhT4_U93QCsfXhDpIdO4j0j08ICdMu-eagS7j3FnfI1d-jy8lJMTs7nk4OZ4UthRwKDo0STNeNQnDQVOhEKRrRWimsQu2gFiwHIeU8_-k8q1OOu8rmes5LLXfIdKXbBliYm-iXEB9MAG9eH0K8NhDzQh0aEBqUZGCd1qXVHMDySjEtUfPaCZW1fq60bmK4HTENZumTxa6DHsOYTD5iqXWGy4z--IIuwhj7vOkr1ZRVxetMfX-jxvkS24_x3k-egV8rwMaQUkT3gXBmXkw1n03NuPiCWz9ku0I_RPDd_5ueAckroOc |
| CitedBy_id | crossref_primary_10_1007_s11883_024_01259_7 crossref_primary_10_3390_metabo15040224 crossref_primary_10_1016_j_archoralbio_2025_106176 crossref_primary_10_3389_fendo_2024_1461642 crossref_primary_10_3233_CH_242435 crossref_primary_10_3389_fendo_2024_1401679 crossref_primary_10_3390_ijms251810146 crossref_primary_10_51249_hs_v4i06_2318 crossref_primary_10_7759_cureus_70262 |
| Cites_doi | 10.2337/diacare.27.10.2450 10.1161/ATVBAHA.119.311998 10.3390/biom13111640 10.1016/j.atherosclerosis.2018.11.015 10.2174/187152508783955006 10.1093/clinchem/hvaa228 10.1152/ajpheart.00509.2016 10.3945/jn.109.113126 10.1016/j.arcmed.2010.08.009 10.2217/fca-2021-0027 10.1016/j.phrs.2023.107050 10.1056/NEJMoa1912388 10.1038/nature01323 10.1038/s41569-020-00480-6 10.1016/j.phrs.2018.12.010 10.1161/JAHA.115.002128 10.1016/j.jcmg.2023.11.014 10.1002/iid3.860 10.1016/j.cyto.2019.154752 10.1093/mtomcs/mfab030 10.1177/23969873231185208 10.1016/j.jacc.2020.08.052 10.1136/bmj.n71 10.1016/j.ecl.2022.02.005 10.1056/NEJMoa1707914 10.1080/1744666X.2022.2045952 10.1186/1471-2288-14-135 10.1177/0003319716633339 10.1097/FJC.0000000000000595 10.1161/JAHA.117.007132 10.1161/01.CIR.0000052939.59093.45 10.1001/jama.297.6.611 10.1371/journal.pone.0135221 10.1161/CIRCULATIONAHA.109.901413 10.1007/978-3-030-33330-0_7 10.1136/jcp.2004.025452 10.2334/josnusd.16-0278 10.1136/bmj.e4947 10.17116/terarkh201688593-101 10.1002/ejhf.146 10.1093/cvr/cvaa083 10.1016/S0140-6736(21)00520-1 10.1136/bmj.h3908 10.1016/j.jacc.2017.05.062 10.1038/s41598-019-47217-1 10.3389/fcvm.2022.818890 10.1161/CIRCULATIONAHA.108.814251 10.1093/eurheartj/ehad486 10.1016/j.atherosclerosis.2017.06.029 10.1016/j.cyto.2023.156261 10.1056/NEJMra043430 10.1177/1708538120921005 10.1016/j.cyto.2017.11.009 |
| ContentType | Journal Article |
| Copyright | 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | AAYXX CITATION NPM 3V. 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 DOA |
| DOI | 10.3390/jcdd11070206 |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni) ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic DOAJ Open Access Full Text |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic Publicly Available Content Database CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X7 name: Health & Medical Collection url: https://search.proquest.com/healthcomplete sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2308-3425 |
| ExternalDocumentID | oai_doaj_org_article_a27a630acf774c71aac156073e718f26 39057626 10_3390_jcdd11070206 |
| Genre | Journal Article Review |
| GrantInformation_xml | – fundername: This research has been funded by the Committee of Science of the Ministry of Science and Higher Education of the Republic of Kazakhstan grantid: BR21882152 |
| GroupedDBID | 53G 5VS 7X7 8FI 8FJ AADQD AAFWJ AAYXX ABUWG ADBBV AFKRA AFPKN AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV BENPR CCPQU CITATION EMOBN FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR ITC KQ8 MODMG M~E OK1 PGMZT PHGZM PHGZT PIMPY RPM UKHRP NPM 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQQKQ PQUKI PRINS 7X8 PUEGO |
| ID | FETCH-LOGICAL-c423t-1a96207896eafa95ef24292dc32c6e7fa820e7f233b5ef7390f6f1f5c3b5b1473 |
| IEDL.DBID | DOA |
| ISSN | 2308-3425 |
| IngestDate | Wed Aug 27 01:22:29 EDT 2025 Thu Jul 10 22:22:11 EDT 2025 Mon Jun 30 12:35:45 EDT 2025 Mon Jul 21 06:08:55 EDT 2025 Tue Jul 01 01:48:20 EDT 2025 Thu Apr 24 23:11:54 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | cardiovascular diseases IL-1β inflammation biomarkers IL-6 |
| Language | English |
| License | https://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c423t-1a96207896eafa95ef24292dc32c6e7fa820e7f233b5ef7390f6f1f5c3b5b1473 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| ORCID | 0000-0002-0747-7712 0000-0001-9668-0327 0000-0001-9479-0899 |
| OpenAccessLink | https://doaj.org/article/a27a630acf774c71aac156073e718f26 |
| PMID | 39057626 |
| PQID | 3084945518 |
| PQPubID | 5046891 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_a27a630acf774c71aac156073e718f26 proquest_miscellaneous_3084777184 proquest_journals_3084945518 pubmed_primary_39057626 crossref_primary_10_3390_jcdd11070206 crossref_citationtrail_10_3390_jcdd11070206 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2024-07-01 |
| PublicationDateYYYYMMDD | 2024-07-01 |
| PublicationDate_xml | – month: 07 year: 2024 text: 2024-07-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland – name: Basel |
| PublicationTitle | Journal of cardiovascular development and disease |
| PublicationTitleAlternate | J Cardiovasc Dev Dis |
| PublicationYear | 2024 |
| Publisher | MDPI AG |
| Publisher_xml | – name: MDPI AG |
| References | Pearson (ref_41) 2003; 107 Blankenberg (ref_7) 2010; 121 Zhang (ref_10) 2010; 41 Libby (ref_2) 2019; 39 Ridker (ref_8) 2007; 297 Gotsman (ref_24) 2014; 16 Matter (ref_47) 2024; 45 ref_19 Gremmels (ref_22) 2019; 9 Ridker (ref_52) 2021; 397 Curtis (ref_14) 2009; 139 ref_16 Feng (ref_54) 2022; 9 Libby (ref_12) 2002; 420 Sokolik (ref_15) 2021; 14 Willeit (ref_17) 2017; 70 Kreiner (ref_42) 2022; 18 Ridker (ref_31) 2008; 118 Bergamaschi (ref_46) 2024; 17 Blais (ref_4) 2019; 280 Ridker (ref_40) 2020; 76 ref_28 Hansson (ref_6) 2005; 352 Robertson (ref_23) 2015; 4 Caiazzo (ref_39) 2024; 200 Shetty (ref_50) 2004; 27 Samuel (ref_44) 2021; 17 Pfeiler (ref_38) 2019; 122 Haller (ref_1) 2021; 67 Page (ref_18) 2021; 372 Albelda (ref_35) 2018; 72 ref_36 Stocking (ref_27) 2023; 8 ref_34 Mishra (ref_53) 2021; 18 Tardif (ref_26) 2019; 381 Milajerdi (ref_11) 2019; 123 Guo (ref_25) 2020; 28 Layden (ref_51) 2012; 345 Popkova (ref_43) 2016; 88 Ridker (ref_29) 2017; 377 Soysal (ref_33) 2020; 1216 Apostolakis (ref_37) 2008; 6 Signorelli (ref_20) 2016; 67 Libra (ref_30) 2006; 59 Bartolomaeus (ref_13) 2020; 116 Parish (ref_3) 2015; 351 ref_49 Tabrizi (ref_9) 2019; 141 Yang (ref_45) 2017; 312 Goldsborough (ref_32) 2022; 51 ref_5 Wytrykowska (ref_48) 2016; 58 Takamura (ref_21) 2017; 263 |
| References_xml | – volume: 27 start-page: 2450 year: 2004 ident: ref_50 article-title: Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes publication-title: Diabetes Care doi: 10.2337/diacare.27.10.2450 – volume: 39 start-page: 1510 year: 2019 ident: ref_2 article-title: Anticytokine Immune Therapy and Atherothrombotic Cardiovascular Risk publication-title: Arterioscler. Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.119.311998 – ident: ref_19 doi: 10.3390/biom13111640 – volume: 280 start-page: 174 year: 2019 ident: ref_4 article-title: Trends in statin prescription prevalence, initiation, and dosing: Hong Kong, 2004–2015 publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2018.11.015 – volume: 6 start-page: 150 year: 2008 ident: ref_37 article-title: IL-1 cytokines in cardiovascular disease: Diagnostic, prognostic and therapeutic implications publication-title: Cardiovasc. Hematol. Agents Med. Chem. doi: 10.2174/187152508783955006 – volume: 67 start-page: 96 year: 2021 ident: ref_1 article-title: Role of Cardiac Biomarkers in Epidemiology and Risk Outcomes publication-title: Clin. Chem. doi: 10.1093/clinchem/hvaa228 – volume: 312 start-page: H265 year: 2017 ident: ref_45 article-title: L5-LDL from ST-elevation myocardial infarction patients induces IL-1β production via LOX-1 and NLRP3 inflammasome activation in macrophages publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.00509.2016 – volume: 139 start-page: 2266 year: 2009 ident: ref_14 article-title: Cardiovascular disease risk biomarkers and liver and kidney function are not altered in postmenopausal women after ingesting an elderberry extract rich in anthocyanins for 12 weeks publication-title: J. Nutr. doi: 10.3945/jn.109.113126 – volume: 41 start-page: 464 year: 2010 ident: ref_10 article-title: Effects of statin therapy on inflammatory markers in chronic heart failure: A meta-analysis of randomized controlled trials publication-title: Arch. Med. Res. doi: 10.1016/j.arcmed.2010.08.009 – volume: 17 start-page: 411 year: 2021 ident: ref_44 article-title: Lessons learned from large Cardiovascular Outcome Trials targeting inflammation in cardiovascular disease (CANTOS, CIRT, COLCOT and LoDoCo2) publication-title: Futur. Cardiol. doi: 10.2217/fca-2021-0027 – volume: 200 start-page: 107050 year: 2024 ident: ref_39 article-title: Circulating cytokines and risk of developing hypertension: A systematic review and meta-analysis publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2023.107050 – volume: 381 start-page: 2497 year: 2019 ident: ref_26 article-title: Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1912388 – volume: 420 start-page: 868 year: 2002 ident: ref_12 article-title: Inflammation in atherosclerosis publication-title: Nature doi: 10.1038/nature01323 – volume: 18 start-page: 400 year: 2021 ident: ref_53 article-title: Cellular and molecular pathobiology of heart failure with preserved ejection fraction publication-title: Nat. Rev. Cardiol. doi: 10.1038/s41569-020-00480-6 – volume: 141 start-page: 85 year: 2019 ident: ref_9 article-title: The effects of statin use on inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2018.12.010 – volume: 4 start-page: e002128 year: 2015 ident: ref_23 article-title: Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome publication-title: J. Am. Heart Assoc. doi: 10.1161/JAHA.115.002128 – volume: 17 start-page: 610 year: 2024 ident: ref_46 article-title: Acute Response of the Noninfarcted Myocardium and Surrounding Tissue Assessed by T2 Mapping After STEMI publication-title: JACC Cardiovasc. Imaging doi: 10.1016/j.jcmg.2023.11.014 – ident: ref_49 doi: 10.1002/iid3.860 – volume: 123 start-page: 154752 year: 2019 ident: ref_11 article-title: Statins influence biomarkers of low grade inflammation in apparently healthy people or patients with chronic diseases: A systematic review and meta-analysis of randomized clinical trials publication-title: Cytokine doi: 10.1016/j.cyto.2019.154752 – ident: ref_28 doi: 10.1093/mtomcs/mfab030 – volume: 8 start-page: 819 year: 2023 ident: ref_27 article-title: Phase II randomised, placebo-controlled, clinical trial of interleukin-1 receptor antagonist in intracerebral haemorrhage: BLOcking the Cytokine IL-1 in ICH (BLOC-ICH) publication-title: Eur. Stroke J. doi: 10.1177/23969873231185208 – volume: 76 start-page: 1774 year: 2020 ident: ref_40 article-title: Targeting Interleukin-1 and Interleukin-6: The Time Has Come to Aggressively Address Residual Inflammatory Risk publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2020.08.052 – volume: 372 start-page: n71 year: 2021 ident: ref_18 article-title: The PRISMA 2020 statement: An updated guideline for reporting systematic reviews publication-title: BMJ doi: 10.1136/bmj.n71 – volume: 51 start-page: 483 year: 2022 ident: ref_32 article-title: Assessment of Cardiovascular Disease Risk: A 2022 Update publication-title: Endocrinol. Metab. Clin. N. Am. doi: 10.1016/j.ecl.2022.02.005 – volume: 377 start-page: 1119 year: 2017 ident: ref_29 article-title: Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1707914 – volume: 18 start-page: 377 year: 2022 ident: ref_42 article-title: Interleukin 6 in diabetes, chronic kidney disease, and cardiovascular disease: Mechanisms and therapeutic perspectives publication-title: Expert. Rev. Clin. Immunol. doi: 10.1080/1744666X.2022.2045952 – ident: ref_16 doi: 10.1186/1471-2288-14-135 – volume: 67 start-page: 870 year: 2016 ident: ref_20 article-title: Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort Study publication-title: Angiology doi: 10.1177/0003319716633339 – volume: 72 start-page: 77 year: 2018 ident: ref_35 article-title: Biologics and Cardiovascular Disease publication-title: J. Cardiovasc. Pharmacol. doi: 10.1097/FJC.0000000000000595 – ident: ref_5 doi: 10.1161/JAHA.117.007132 – volume: 107 start-page: 499 year: 2003 ident: ref_41 article-title: Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association publication-title: Circulation doi: 10.1161/01.CIR.0000052939.59093.45 – volume: 297 start-page: 611 year: 2007 ident: ref_8 article-title: Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: The Reynolds Risk Score publication-title: JAMA doi: 10.1001/jama.297.6.611 – ident: ref_34 doi: 10.1371/journal.pone.0135221 – volume: 121 start-page: 2388 year: 2010 ident: ref_7 article-title: Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: The MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.901413 – volume: 1216 start-page: 55 year: 2020 ident: ref_33 article-title: Inflammation, Frailty and Cardiovascular Disease publication-title: Adv. Exp. Med. Biol. doi: 10.1007/978-3-030-33330-0_7 – volume: 59 start-page: 211 year: 2006 ident: ref_30 article-title: Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease publication-title: J. Clin. Pathol. doi: 10.1136/jcp.2004.025452 – volume: 58 start-page: 509 year: 2016 ident: ref_48 article-title: IL-1β, TNF-α, and IL-6 levels in gingival fluid and serum of patients with ischemic stroke publication-title: J. Oral Sci. doi: 10.2334/josnusd.16-0278 – volume: 345 start-page: e4947 year: 2012 ident: ref_51 article-title: Diagnosis and management of lower limb peripheral arterial disease: Summary of NICE guidance publication-title: BMJ doi: 10.1136/bmj.e4947 – volume: 88 start-page: 93 year: 2016 ident: ref_43 article-title: Interleukin-6 inhibition and cardiovascular disease in patients with rheumatoid arthritis publication-title: Ter. Arkh. doi: 10.17116/terarkh201688593-101 – volume: 16 start-page: 1190 year: 2014 ident: ref_24 article-title: Impaired fasting glucose: A predictor of reduced survival in patients with heart failure publication-title: Eur. J. Heart Fail. doi: 10.1002/ejhf.146 – volume: 116 start-page: 1252 year: 2020 ident: ref_13 article-title: Blood pressure changes correlate with short-chain fatty acid production potential shifts under a synbiotic intervention publication-title: Cardiovasc. Res. doi: 10.1093/cvr/cvaa083 – volume: 397 start-page: 2060 year: 2021 ident: ref_52 article-title: IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): A double-blind, randomised, placebo-controlled, phase 2 trial publication-title: Lancet doi: 10.1016/S0140-6736(21)00520-1 – volume: 351 start-page: h3908 year: 2015 ident: ref_3 article-title: Statins for people at low risk publication-title: BMJ doi: 10.1136/bmj.h3908 – volume: 70 start-page: 558 year: 2017 ident: ref_17 article-title: High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2017.05.062 – volume: 14 start-page: 157 year: 2021 ident: ref_15 article-title: Relationship Between Interleukin-6-174G/C Genetic Variant and Efficacy of Methotrexate Treatment in Psoriatic Arthritis Patients publication-title: Pharmgenomics Pers. Med. – volume: 9 start-page: 10740 year: 2019 ident: ref_22 article-title: A Pro-Inflammatory Biomarker-Profile Predicts Amputation-Free Survival in Patients with Severe Limb Ischemia publication-title: Sci. Rep. doi: 10.1038/s41598-019-47217-1 – volume: 9 start-page: 818890 year: 2022 ident: ref_54 article-title: The Role of Interleukin-6 Family Members in Cardiovascular Diseases publication-title: Front. Cardiovasc. Med. doi: 10.3389/fcvm.2022.818890 – volume: 118 start-page: 2243 year: 2008 ident: ref_31 article-title: C-reactive protein and parental history improve global cardiovascular risk prediction: The Reynolds Risk Score for men publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.814251 – volume: 45 start-page: 89 year: 2024 ident: ref_47 article-title: Inflammation in acute myocardial infarction: The good, the bad and the ugly publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehad486 – volume: 263 start-page: 192 year: 2017 ident: ref_21 article-title: Circulating malondialdehyde-modified low-density lipoprotein (MDA-LDL) as a novel predictor of clinical outcome after endovascular therapy in patients with peripheral artery disease (PAD) publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2017.06.029 – ident: ref_36 doi: 10.1016/j.cyto.2023.156261 – volume: 352 start-page: 1685 year: 2005 ident: ref_6 article-title: Inflammation, atherosclerosis, and coronary artery disease publication-title: N. Engl. J. Med. doi: 10.1056/NEJMra043430 – volume: 28 start-page: 715 year: 2020 ident: ref_25 article-title: Six-month results of stenting of the femoropopliteal artery and predictive value of interleukin-6: Comparison with high-sensitivity C-reactive protein publication-title: Vascular doi: 10.1177/1708538120921005 – volume: 122 start-page: 154215 year: 2019 ident: ref_38 article-title: IL-1 family cytokines in cardiovascular disease publication-title: Cytokine doi: 10.1016/j.cyto.2017.11.009 |
| SSID | ssj0001342012 |
| Score | 2.4204695 |
| SecondaryResourceType | review_article |
| Snippet | Cardiovascular diseases (CVDs) are a leading cause of global morbidity and mortality, significantly driven by chronic inflammation. Interleukin-6 (IL-6) and... |
| SourceID | doaj proquest pubmed crossref |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source |
| StartPage | 206 |
| SubjectTerms | Amputation Angioplasty Atherosclerosis biomarkers Cardiovascular disease cardiovascular diseases Clinical outcomes Clinical trials Coronary vessels Cytokines Heart attacks Heart failure IL-1β IL-6 Inflammation Ischemia Mortality Pathology Patients Systematic review Vein & artery diseases |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagSIgL4k3agozUnpDVxHbszQlB29UCXQ6FlfYWOX5URaukdLd_rD-kv4mZ2JtlD-WUhyeWM37M55nxDCEHVShDzpuSmbLKmXRlwUZSWua5K7ltRGE9HnCe_lCTmfw2L-dJ4bZMbpXrNbFfqF1nUUd-JPKRrCTGD_t09Ydh1ii0rqYUGg_JIwxdhi5deq43OhYhQb7x6O8uYHd_9Ns6hzseAElqSxL1AfvvR5m9tBk_I08TTKSfY78-Jw98-4I8niZD-Evy_ecQgZlG9T7tWgpgjp53C0-7QL-eMUVN6_CmuLully093vI9pSfRNrN8RWbj01_HE5byIjAL4GfFClMpjmHilTfBVKUPHJNOOSu4VV4HA1IdLlyIBso0_HdQoQilheemkFq8Jjtt1_q3hAYnOYcP8uC0NJU3HlYAr2VlQEw5n2fk45pHtU1BwzF3xaKGzQNytP6Xoxk5HKivYrCMe-i-ILsHGgxx3b_ori_qNGNqw7VRIjc2AEK1ujDG4qlvDc0rRoFDJfvrzqrTvFvWm1GSkQ9DMcwYNIOY1nc3kUZrqERm5E3s5KEl0FLYgHG1-__K98gTDuAmuu3uk53V9Y1_B-Bk1bzvR-Bfk_Xhkw priority: 102 providerName: ProQuest |
| Title | Systematic Review on the Role of IL-6 and IL-1β in Cardiovascular Diseases |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/39057626 https://www.proquest.com/docview/3084945518 https://www.proquest.com/docview/3084777184 https://doaj.org/article/a27a630acf774c71aac156073e718f26 |
| Volume | 11 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1JS8UwEB5cQLyIu3V5RNCTFNskTezR91TcERd4t5JmAUVa0ecf84f4m5w0tTwP4sVTl6RlOtN0vkmm3wDs5C5zCS2zWGV5EnOTpfEB5zq21GRUlyzV1v_gfHUtTh_4-TAbjpX68jlhgR44KG5fUakES5R2CFS0TJXS_udfySx-VR1tyLbR540FU83sCuPo2WjIdGcY1-8_aWN8rIPwSPzwQQ1V_-_4svEzJ_Mw1wJEchgEW4AJWy3CzFW7BL4EF3cd9zIJE_ukrgjCOHJbP1tSO3J2GQuiKuN30s8P8liRwY-sU3IUVmXeluHh5Ph-cBq3FRFijbBnFKcqF9QTxAurnMoz66gvN2U0o1pY6RT6c9xQxkpsk_jcTrjUZRqPy5RLtgJTVV3ZNSDOcErxgsQZyVVulcWxbyXPFTooY5MI9r51VOiWLtxXrXguMGzwGi3GNRrBbtf7JdBk_NKv79Xd9fHk1s0JNHnRmrz4y-QRbH4bq2hH3FvBkgOec88vF8F214xjxS-AqMrW76GPlHgTHsFqMHInCUqKoRcV6_8h4QbMUgQ_Ia13E6ZGr-92C8HLqOzBpBzKHkz3j69vbnvNW_sF6qPsLQ |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbhQxzCpbCbgg3l1oIUj0hKLOJJlk54BQn9plH0KllXobMnlUoGqmdLdC_BQHPoRvwtnMTOmh3HqaRxwrcuzYjhMb4G3uM5-wMqM6yxMqbJbSgRCGOmYzZkqeGhcuOE9ncngsPp5kJyvwq70LE45VtmvicqG2tQl75Fs8GYhchPxhH86_01A1KkRX2xIakS3G7ucPdNnm70d7OL-bjB3sH-0OaVNVgBo0HRY01blkIcm6dNrrPHOehZJN1nBmpFNeo07EB-O8xDbF88RLn_rM4HeZCsUR7x1YFRxdmR6s7uzPPh1e7epwgRqVxRP2HPtufTPWBh8LzTJ5TfctSwTcbNcu9dvBQ3jQGKZkO3LSI1hx1WO4O21C709g_LnL-UxiQIHUFUHzkRzWZ47UnowmVBJd2fCS_vlNvlZk99ppV7IXo0Hzp3B8KzR7Br2qrtwaEG8FY9gh8VYJnTvtcM1xSuQaFaN1SR_etTQqTJOmPFTLOCvQXQkULf6laB82O-jzmJ7jBridQO4OJiTVXv6oL06LRkYLzZSWPNHGo01sVKq1CffMFQ4vHXiGSNbbySoaSZ8XV3zZhzddM8poCLzoytWXEUYpRCL68DxOcjcSHCm6fEy--D_y13BveDSdFJPRbPwS7jM0reKh4XXoLS4u3QaaRovyVcOPBL7ctgj8BTSeH78 |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbhQxzCpFqrggyqsLBYJETyjayWOSnQOqaJdVl20rBFTa25DJA4GqmdLdCvFbHPsR_aY68yo9lFtP80hiRY4d27FjA7zJQhoSXqTUpFlCpUsZHUlpqecu5bYQzPp4wfngUO0dyY_zdL4C591dmBhW2e2J9UbtKhvPyIciGclMxvxhw9CGRXwaT7ZPftFYQSp6WrtyGg2JzPyf32i-Ld5Nx7jWW5xPPnzd3aNthQFqUY1YUmYyxWPCdeVNMFnqA4_lm5wV3Cqvg0H5iA8uRIFtWmRJUIGF1OJ3waQWCPcO3NUiZZHH9Fxfne8IibKVN7H2AkcOf1rnorWFCpq6JgXrYgE3a7i1pJs8gPutikreNzS1Diu-fAhrB60T_hHMvvTZn0njWiBVSVCRJJ-rY0-qQKb7VBFTuvjCLv6SHyXZvRb3SsaNX2jxGI5uBWNPYLWsSr8BJDjJOQ5IgtPSZN543H28lplBEel8MoC3HY5y2yYsj3UzjnM0XCJG838xOoCtvvdJk6jjhn47Ed19n5heu_5RnX7PW27NDddGicTYgNqx1cwYG2-ca5weGwWOQDa7xcpbnl_kVxQ6gNd9M3JrdMGY0ldnTR-tEYgcwNNmkfuZ4EzR-OPq2f-Bv4I1JPx8f3o4ew73OOpYTfTwJqwuT8_8C9SRlsXLmhgJfLtt6r8Ejqgijw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Systematic+Review+on+the+Role+of+IL-6+and+IL-1%CE%B2+in+Cardiovascular+Diseases&rft.jtitle=Journal+of+cardiovascular+development+and+disease&rft.au=Nurlubek+Katkenov&rft.au=Zhussipbek+Mukhatayev&rft.au=Samat+Kozhakhmetov&rft.au=Aliya+Sailybayeva&rft.date=2024-07-01&rft.pub=MDPI+AG&rft.eissn=2308-3425&rft.volume=11&rft.issue=7&rft.spage=206&rft_id=info:doi/10.3390%2Fjcdd11070206&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_a27a630acf774c71aac156073e718f26 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2308-3425&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2308-3425&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2308-3425&client=summon |